gemfibrozil has been researched along with Neurodegenerative Diseases in 2 studies
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, A | 1 |
| Pahan, K | 2 |
| Corbett, GT | 1 |
| Roy, A | 1 |
2 other studies available for gemfibrozil and Neurodegenerative Diseases
| Article | Year |
|---|---|
Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders.
Topics: Base Sequence; Cells, Cultured; DNA Primers; Gemfibrozil; Humans; Hypolipidemic Agents; Kruppel-Like | 2012 |
Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense.
Topics: Animals; Apoptosis Regulatory Proteins; Cells, Cultured; Cerebral Cortex; Gemfibrozil; Humans; Hypol | 2012 |